View drug registration information details.
| Items | Registration information |
|---|
| ID | 187 |
|---|
| No | 187 |
|---|
| Brand Name | CAPIVADX |
|---|
| Ingredients | CAPIVASERTIB 160 MG |
|---|
| Dosage Form | FILM COATED TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | STORE BELOW 30 C |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | BOX OF 64'S/BOTTLE |
|---|
| Dispensing Category | PRESCRIPTION |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | ANTINEOPLASTIC |
|---|
| Indications | IN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF ADULT PATIENTS WITH HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 NEGATIVE, LOCALLY ADVANCED OR MESTASTATIC BREAST CANCER WITH ONE OR MORE PIK2CA/AKT1/PTEN-ALTERATIONS |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
No |
|---|
| Description | ORANGE FILM COATED TABLET, LETTER BB ON ONE SIDE AND PLAN ON THE OTHER SIDE |
|---|
| Note | |
|---|
| License Owner | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
|---|
| Manufacturer | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 12 L 1267/24 |
|---|
| FDD Registration Date | 2024-12-25 |
|---|
| Expiry Date | 2029-12-24 |
|---|
Back to drug list
|
